Evidence map›Paper›PMID 21709060›Full record

Trial reportCirculation2011

Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial.

Rajendra H Mehta, T Bruce Ferguson, Renato D Lopes, Gail E Hafley, Michael J Mack, Nicholas T Kouchoukos, C Michael Gibson, Robert A Harrington, Robert M Califf, Eric D Peterson and 2 more

Registry-linked trialAbstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Circulation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05129228 (Intraoperative Optical Coherence Tomography of the Saphenous Vein Conduit in Patients Undergoing Coronary Artery Bypass Surgery), which is not on this map. Cited by 34 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05129228 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Intraoperative Optical Coherence Tomography of the Saphenous Vein Conduit in Patients Undergoing Coronary Artery Bypass Surgery

TypeinterventionalSponsorSt. Francis Hospital, New YorkRan2022 to 2026Enrolled760ConditionsCoronary Bypass Graft StenosisArmsOCT-guided saphenous vein CABG
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Influence of graft anastomosis and graft morphology on long-term patency of the saphenous vein after aortocoronary bypass.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Observational
  17. Review
  18. Review
  19. A review of hybrid coronary revascularization.Indian journal of thoracic and cardiovascular surgery · 2018
    Review
  20. The radial artery in coronary surgery, 2018.Indian journal of thoracic and cardiovascular surgery · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Rajendra H MehtaDuke Clinical Research Institute, Box 17969, Durham, NC 27715, USA. mehta007@dcri.duke.edu
T Bruce Ferguson
Renato D Lopes
Gail E Hafley
Michael J Mack
Nicholas T Kouchoukos
C Michael Gibson
Robert A Harrington
Robert M Califf
Eric D Peterson
John H Alexander
Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Investigators

Funding

Cardiothoracic Surgical Network Clinical CenterU01HL088953 · NHLBI · DUKE UNIVERSITY · PI SMITH, PETER K · 2007 to 2013
$2.6M
Core Clinical Centers for the CTSNUM1HL088953 · NHLBI · DUKE UNIVERSITY · PI SMITH, PETER K · 2013 to 2017
$2.5M
NHLBI NIH HHS U01 HL088953NHLBI NIH HHS U01-HL088953NHLBI NIH HHS UM1 HL088953
6 · The paper itself

Abstract

backgroundLimited information exists on the intermediate-term graft patency and 5-year clinical outcomes of patients receiving saphenous vein grafts with multiple (m-SVG) versus single distal targets (s-SVG) during coronary artery bypass graft (CABG) surgery in the current era. METHODS AND

resultsWe studied the association of the use of m-SVG versus s-SVG conduits with 1-year SVG failure (defined as ≥75% angiographic stenosis) and 5-year clinical events (death; death or myocardial infarction [MI]; and death, MI, or revascularization) in 3014 patients undergoing their first CABG surgery enrolled in the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV. Of 3014 patients enrolled in PREVENT IV, 1045 (34.7%) had ≥1 m-SVGs during CABG. Vein graft failure at 1-year was higher for m-SVG compared with s-SVG (adjusted odds ratio 1.24, 95% confidence interval 1.03 to 1.48). At 5 years, the adjusted composite of death, MI (including perioperative MI), or revascularization (hazard ratio 1.15, 95% confidence interval 1.00 to 1.31) and death or MI (hazard ratio 1.21, 95% confidence interval 1.03 to 1.43) were significantly higher in patients receiving m-SVGs.

conclusionsIn patients undergoing first CABG surgery, the use of m-SVG was associated with a higher 1-year vein graft failure rate and trends toward worse clinical outcomes. Additional studies are needed to better understand the most appropriate conduit to improve long-term graft patency and clinical outcomes of patients undergoing CABG surgery. In the meantime, these data should encourage the use of s-SVG over m-SVG when feasible.

Indexed as

Blood Vessel ProsthesisGraft RejectionTransfectionAgedAnastomosis, SurgicalCoronary Artery BypassCoronary Artery DiseaseCoronary VesselsDouble-Blind MethodFollow-Up StudiesGraft SurvivalHumansIncidenceLongitudinal StudiesMaleMiddle Aged

Identifiers

PMID21709060
PMCPMC5144829

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.